{"Id":"c9e428a5-39f5-4387-8494-ac2b91a0d423","CanonicalId":"Weblink [doi not issued]","Url":"https://www.cellr4.org/article/2489","Name":"POSEIDON study: a pilot, safety and feasibility trial of high­-dose omega­3 fatty acids and high-­dose cholecalciferol supplementation in type 1 diabetes","Description":"A clinical protocol for a proposed POSEIDON clinical trial that will test the use of high dose vitamin D3 and highly purified Omega-3 fatty acids in new onset and established T1D. The draft of the study protocol, in addition to the informed consent and assent, is now shared open access to facilitate its international implementation by interested physicians and centers that would like to further test this approach through clinical trials.\n","ResourceType":"Protocol","ParentResourceType":null,"DefiningManuscriptId":"","Publications":[],"Contributors":[{"Role":{"CanonicalId":"hirn-cv-ResourceRole-producer","Url":"resources.hirnetwork.org/api/v1/CV/","Name":"Producer","OntologyId":"HIRN"},"HirnUserId":"camillo_ricordi@hirnetwork.org","FirstName":"Camillo","LastName":"Ricordi","EmailAddress":"ricordi@miami.edu","Organization":"University of Miami","Consortia":["CHIB","HPAC","CTAR"]}],"Vendor":{"id":null,"Name":"","Url":null},"VendorResourceName":null,"VendorResourceUrl":"","VendorCatNumber":"","VendorLotNumber":"","DateCreated":"2021-08-24T16:36:57.8784751+00:00","DateModified":"2022-07-01T03:36:55.5864279+00:00","VersionId":"5","ModelVersion":"4.0","ProtocolData":{"ProtocolType":{"CanonicalId":null,"Url":null,"Name":null,"OntologyId":null},"DocumentId":null,"ProtocolSpecies":[],"DocumentTopic":[]}}